These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3248945)

  • 21. Comparative activities of three new antibacterial agents with aztreonam against gram-negative bacilli.
    Kafetzis DA; Legakis NJ
    Chemioterapia; 1987 Jun; 6(2 Suppl):110-2. PubMed ID: 3151330
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro study of the sensitivity of 1030 hospital-isolated bacterial strains to aztreonam.
    Grassi L
    Chemioterapia; 1984 Aug; 3(4):262-6. PubMed ID: 6543433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro antibacterial activity of imipenem and other agents against gram-negative and gram-positive strains isolated from clinical specimens.
    Bartoloni A; Colao MG; Giganti E; Orsi A; Aquilini D; Corti G; Paradisi F
    G Ital Chemioter; 1988; 35(1-3):1-5. PubMed ID: 3256508
    [No Abstract]   [Full Text] [Related]  

  • 24. [Surveillance on drug resistance of gram-negative bacilli isolated from hospital acquired infections and community acquired infections (2000 - 2001)].
    Li JT; Li Y; Wang J;
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1035-45. PubMed ID: 12899774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro antimicrobial activity of CI-919 against gram-negative bacilli and Staphylococcus aureus isolated from various pathologies].
    Prado V; Reyes L
    Rev Med Chil; 1985 Feb; 113(2):94-102. PubMed ID: 3866270
    [No Abstract]   [Full Text] [Related]  

  • 26. Correlation of aztreonam susceptibility results obtained with the MicroScan system to reference tests.
    Zimmer BL; Brattebo J; Bryant M; Capo A; Chipman A; Miller R; Wehr C; Van Pelt L
    Diagn Microbiol Infect Dis; 1997 Oct; 29(2):111-20. PubMed ID: 9368088
    [No Abstract]   [Full Text] [Related]  

  • 27. In-vitro susceptibility to aztreonam.
    Lim VK
    Malays J Pathol; 1988 Aug; 10():61-4. PubMed ID: 3252078
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of the inhibitory and bactericidal activity of aztreonam and amikacin against gram negative aerobic bacilli.
    Fung-Tomc JC; Lincourt W; Thater C; Kessler RE
    Ann Clin Lab Sci; 1988; 18(6):463-7. PubMed ID: 3239949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing antimicrobial resistance in gram-negative bacilli isolated from patients in intensive care units.
    Flournoy DJ; Reinert RL; Bell-Dixon C; Gentry CA
    Am J Infect Control; 2000 Jun; 28(3):244-50. PubMed ID: 10840345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Distribution of pathogen and resistance of nosocomial infections in the intensive care units].
    Dai CM; Zhou JD; Wu Y; Qi Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):277-80. PubMed ID: 16706133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative in vitro activity of eight antibiotics against Pseudomonas aeruginosa and infrequently isolated gram-negative bacilli.
    Chiaradia V; Pascoli L; Santini G
    Chemioterapia; 1985 Aug; 4(4):284-8. PubMed ID: 3931923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antibiotic sensitivity of gram-negative bacteria in intensive care units in Switzerland].
    Wüst J; Auckenthaler R; Breer C; Frei R; Heinzer I; Kamm W
    Schweiz Med Wochenschr; 1994 Oct; 124(39):1695-700. PubMed ID: 7939535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis.
    Alhanout K; Brunel JM; Raoult D; Rolain JM
    J Antimicrob Chemother; 2009 Oct; 64(4):810-4. PubMed ID: 19666647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
    Xiao QZ; Su DH; Jiang JH; Zhong NS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative in vitro study of the antibacterial effect of cefotetan against gram-positive and gram-negative aerobic and anaerobic strains from fresh clinical isolates.
    Klietmann W; Focht J; Nösner K
    Chemioterapia; 1987 Jun; 6(2 Suppl):92-3. PubMed ID: 3509542
    [No Abstract]   [Full Text] [Related]  

  • 36. Susceptibility of clinical isolates of gram-positive and gram-negative organisms to cefatrizine.
    Carlone NA; Cuffini AM; Forno Pizzoglio M; Cavallo G
    Drugs Exp Clin Res; 1985; 11(7):447-51. PubMed ID: 3836867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Enzymatic mechanisms of resistance to aminoglycoside antibiotics in gram negative bacilli from Chilean hospitals].
    Del Solar E; García A; Bello H; Domínguez M; González G; Zemelman R
    Rev Med Chil; 1995 Mar; 123(3):293-7. PubMed ID: 8525167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Azthreonam: in vitro activity.
    Gobernado M; Cantón E; Santos M
    Microbiol Esp; 1983; 36(3-4):123-32. PubMed ID: 6687197
    [No Abstract]   [Full Text] [Related]  

  • 39. [In vitro evaluation of the antibiotic effect of imipenen on bacterial strains isolated mostly from compromised patients].
    Bartolucci M; Galluzzi F; Sanchioni G; Aureli G
    Quad Sclavo Diagn; 1988; 24(1-4):203-12. PubMed ID: 3268913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sensitivity of nonfermenting gram-negative bacteria of clinical origin to antibacterial preparations].
    Shchenderov BA; Serkova GP; Tiurin MV
    Antibiotiki; 1984 Mar; 29(3):191-5. PubMed ID: 6732205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.